You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 520 Initial strategy of corticosteroids-immunosuppressant treatment and the consequent clinical outcome among non-small cell lung cancer patients with severe checkpoint inhibitor pneumonitis

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
520 Initial strategy of corticosteroids-immunosuppressant treatment and the consequent clinical outcome among non-small cell lung cancer patients with severe checkpoint inhibitor pneumonitis
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address